## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `pt-141-gut`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/pt-141-gut/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-gut/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-gut/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/pt-141-gut/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-gut/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/pt-141-gut/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `pt-141-gut` v2 · content_hash `6e5f2b4e764a1f2a…` · thread_head genesis · 19 DIVs
- **thesis (c1):** Bremelanotide is approved for HSDD and commonly causes nausea in ~40% of users in phase 3 trials.
  - c2 [preclinical/active] No published human or animal studies show PT-141 repairing intestinal tissue or improving gut motility disorders.
  - c3 [anecdotal/active] Reddit users report nausea or stomach upset as the dominant gut-related experience with PT-141.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/pt-141-gut/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/pt-141-gut/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `pt-141-gut`
- **title:** PT-141 for Gut: Evidence Review
- **url:** https://miscsubjects.com/a/pt-141-gut
- **register:** source_ledger
- **updated:** 2026-07-17T02:41:06.553Z
- **tags:** peptide, matrix

## Body

## What's breaking down

Gut issues often involve layers of degeneration where repair pathways lag behind ongoing stress or inflammation. The melanocortin system, which PT-141 targets in the central nervous system, has some presence in broader physiology, but direct links to intestinal tissue repair remain unexplored in available data. If your gut symptoms tie into central arousal or motivation pathways, or if side effects like nausea appear, that context matters. PT-141 is not positioned as a gut-specific compound.

## Why PT-141 might help you

1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

PT-141 acts centrally on melanocortin receptors, primarily MC4R in the hypothalamus. This pathway influences arousal and motivation. For someone whose gut complaints overlap with disrupted CNS signaling (such as stress-related motility changes), the discussion centers on whether central activation could indirectly support gut-brain communication. No direct tissue repair data exists for intestinal lining or microbiome balance. If your gut problem stems from mechanical or inflammatory breakdown rather than CNS arousal, this mechanism does not address those layers. Side effect reports note slowed gastric emptying and nausea, which could add mechanical load or discomfort rather than relieve it.

## How these fit together

Single-compound focus. PT-141 maps to the sexual / CNS arousal layer. If your condition profile includes a multi-peptide stack, siblings would target other layers listed in the condition profile. Here the focus stays on one compound and one primary layer.

## What the evidence actually shows

Human trials of bremelanotide focus on hypoactive sexual desire disorder. Two phase 3 studies measured desire scores and distress but did not assess gastrointestinal endpoints beyond recording adverse events. Nausea occurred in roughly 40 percent of participants at the approved dose, with some reports of stomach pain and slowed gastric emptying. These effects led to cautions for people with existing bowel motility problems. Preclinical work includes one rabbit ileum study where alpha-MSH (related but not identical) produced relaxation; bremelanotide itself showed no comparable effect at the tested concentration. No rodent or human studies demonstrate PT-141 repairing gut mucosa, reducing inflammation markers, or improving motility in disease models. Anecdotal reports on forums mention nausea or stomach upset after use, with no consistent claims of gut improvement.

## What scientists say

Published reviews describe bremelanotide as a melanocortin agonist acting in the medial preoptic area to increase dopamine release linked to sexual motivation. Gastrointestinal effects appear only in safety sections as dose-dependent adverse events. Researchers note the drug's metabolism involves peptide hydrolysis, with no identified gut-protective pathway. Functional MRI studies in women with HSDD show changes in sexual brain processing but do not extend to gut regions or autonomic control of digestion.

## What people say on Reddit

Users in threads about PT-141 experiences frequently list nausea, stomach discomfort, or vomiting as first-dose effects that may lessen with repeated lower dosing or antihistamine pretreatment. Some report taking the compound on an empty stomach to reduce queasiness. No posts describe resolution of IBS, ulcer healing, or improved digestion; discussions stay centered on sexual response and side-effect management. Several users note the peptide is destroyed if taken orally due to digestion.

## What people say on X

Posts referencing PT-141 rarely mention gut outcomes. Occasional comments link the compound to broader peptide stacks or note transient nausea. One post in a Huberman Lab discussion thread lists PT-141 alongside other peptides without gut-specific claims. Sentiment remains focused on libido effects rather than digestive repair.

## What we do not know

No controlled human data exist on PT-141 for any primary gut condition. Long-term effects on gastric emptying or microbiome composition are unstudied. Whether central melanocortin activation could produce secondary benefits in stress-sensitive gut disorders remains speculative. Animal models of intestinal disease have not tested this compound.

## Safety and limits

Common side effects include nausea, flushing, and headache. The drug carries a caution for use in people with slow gastric emptying because it may worsen the condition and alter absorption of oral medications. It is administered by subcutaneous injection. Evidence grade for any gut benefit is absent; available information addresses sexual function and lists gastrointestinal adverse events. Readers should consult primary sources and qualified professionals for personal decisions.

## Claims (3)

- **c1** [human w=0.8] Bremelanotide is approved for HSDD and commonly causes nausea in ~40% of users in phase 3 trials.
  - who_claims: grok/grok-4.3
  - sources: s0, s4
- **c2** [preclinical w=0.5] No published human or animal studies show PT-141 repairing intestinal tissue or improving gut motility disorders.
  - who_claims: grok/grok-4.3
  - sources: s22
- **c3** [anecdotal w=0.3] Reddit users report nausea or stomach upset as the dominant gut-related experience with PT-141.
  - who_claims: grok/grok-4.3
  - sources: s15

## Voxel graph (3 atoms · 7 edges)
- full graph: https://miscsubjects.com/api/articles/pt-141-gut/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (4)
- chain valid: yes · head: `0bc46685450ce81e`

### s0 · medical · http_403
- title: Bremelanotide (subcutaneous route) - Side effects & dosage
- url: https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805
- summary: Mayo Clinic entry lists GI cautions and common side effects including nausea and stomach pain.
- quote: Stomach or bowel problem (eg, slow gastric emptying)—Use with caution. May make this condition worse and decrease the absorption of oral medicines.
- claim_ids: c1
- hash: `5249c405c2cd8485`

### s4 · other · ok
- title: PT-141 FOR MEN
- url: https://mensreproductivehealth.com/pt-141-for-men-a-new-drug-to-treat-erectile-dysfunction-and-low-libido/
- summary: Summarizes trial nausea rates and gastric emptying effects.
- quote: about 40% of people (based on female trials) experienced nausea after a 1.75 mg dose
- claim_ids: c1
- hash: `46616f84ff4bf6fb`

### s15 · reddit · ok
- title: PT-141 Experience
- url: https://www.reddit.com/r/erectiledysfunction/comments/1qik4vm/pt141_experience_it_absolutely_works/
- summary: User discussion of administration and side effects.
- quote: No pill form as it is a peptide it would be digested in the stomach.
- claim_ids: c3
- hash: `0bc46685450ce81e`

### s22 · pubmed · ok
- title: Pharmacological profiling of neuropeptides on rabbit ileum
- url: https://pubmed.ncbi.nlm.nih.gov/18587425/
- summary: Only related compound showed effect; bremelanotide did not.
- quote: The melanocortin agonist alpha-melanocortin-stimulating hormone (1 microM), but not bremelanotide (1 microM), also relaxed both preparations.
- claim_ids: c2
- hash: `8e998c5e33732bb8`

## Provenance (2 model passes)
- chain valid: yes · head: `713515c37a40d09f`

- write · grok/grok-4.3 · 2026-06-30T01:16 · hash `ddfeed84cf26`
- voxel_divide · owner · 2026-07-17T02:41 · hash `713515c37a40`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/pt-141-gut/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/pt-141-gut/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"pt-141-gut","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest pt-141-gut|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim pt-141-gut|tier|assertion`
- **iMessage ask:** `pt-141-gut|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `pt-141-gut`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-gut/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-gut/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*